amifostine anhydrous has been researched along with Infections in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Infections: Invasion of the host organism by microorganisms or their toxins or by parasites that can cause pathological conditions or diseases.
Excerpt | Relevance | Reference |
---|---|---|
"Also grade III or IV infections (P=0." | 2.71 | A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem cell transplantation. ( Chow, H; Chuah, CT; Fook, SC; Goh, YT; Hwang, WY; Koh, LP; Ng, HJ; Tan, CH; Tan, KW; Tan, PH; Wong, C, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hwang, WY | 1 |
Koh, LP | 1 |
Ng, HJ | 1 |
Tan, PH | 1 |
Chuah, CT | 1 |
Fook, SC | 1 |
Chow, H | 1 |
Tan, KW | 1 |
Wong, C | 1 |
Tan, CH | 1 |
Goh, YT | 1 |
1 trial available for amifostine anhydrous and Infections
Article | Year |
---|---|
A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Female; Graft Surviva | 2004 |